Valuation: Moderna, Inc.

Market Cap 25.28B 37,603B 21.83B 20.5B 18.67B 35.07B 2,417B 35.58B 240B 94.09B 1,211B 94.9B 92.84B 4,029B P/E 2026 *
-7.51x
P/E 2027 * -13.1x
Enterprise Value 21.63B 32,175B 18.68B 17.54B 15.97B 30.01B 2,068B 30.44B 206B 80.5B 1,036B 81.21B 79.44B 3,448B EV / Sales 2026 *
10.3x
EV / Sales 2027 * 9.47x
Free-Float
92.68%
Yield 2026 *
-
Yield 2027 * -
1 day-1.04%
1 week+5.82%
Current month+12.73%
1 month+1.16%
3 months+36.07%
6 months+58.69%
Current year+110.94%
1 week 4,900
Extreme 4900
5,465
1 month 4,372.5
Extreme 4372.5
5,465
Current year 2,385
Extreme 2385
7,210
1 year 1,670
Extreme 1670
7,210
3 years 1,380
Extreme 1380
11,150
5 years 1,380
Extreme 1380
11,150
10 years 1,380
Extreme 1380
11,150
Manager TitleAgeSince
Chief Executive Officer 54 2011-02-28
Director of Finance/CFO 49 2022-09-05
President 50 2024-10-31
Director TitleAgeSince
Chairman 63 2012-01-31
Director/Board Member 54 2011-02-28
Director/Board Member 69 2019-12-10
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+5.82% - - 25.28B
+0.30%+2.75%+38.86%+1.08% 80.23B
-1.02%-0.51%-2.54%+28.91% 50.64B
+1.46%-3.45%+11.90%+164.29% 46.87B
-1.39%+1.82%-50.22%-50.44% 46.34B
-0.32%+0.58%+50.90%-21.15% 31B
+1.80%+8.94%+130.05%-34.84% 25.28B
+2.78%+2.44%+42.08%+90.79% 24.36B
+1.65%+0.53%-2.21%+190.26% 20.81B
+3.95%+1.02%+67.20%+117.59% 16.08B
Average +0.47%+0.35%+31.78%+54.05% 37.96B
Weighted average by Cap. +0.17%+0.53%+23.84%+39.34%

Financials

2026 *2027 *
Net sales 2.11B 3,133B 1.82B 1.71B 1.56B 2.92B 201B 2.96B 20.03B 7.84B 101B 7.91B 7.74B 336B 2.43B 3,612B 2.1B 1.97B 1.79B 3.37B 232B 3.42B 23.1B 9.04B 116B 9.12B 8.92B 387B
Net income -3.38B -5,026B -2.92B -2.74B -2.49B -4.69B -323B -4.76B -32.14B -12.58B -162B -12.69B -12.41B -539B -1.92B -2,862B -1.66B -1.56B -1.42B -2.67B -184B -2.71B -18.3B -7.16B -92.14B -7.22B -7.07B -307B
Net Debt -3.65B -5,428B -3.15B -2.96B -2.69B -5.06B -349B -5.14B -34.71B -13.58B -175B -13.7B -13.4B -582B -2.27B -3,379B -1.96B -1.84B -1.68B -3.15B -217B -3.2B -21.6B -8.45B -109B -8.53B -8.34B -362B
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (96.1%); - revenue from collaboration agreements (1.5%); - revenue from royalties and licensing (1.3%); - revenue from grants (1.1%). At the end of 2024, the group's portfolio comprises 37 products in clinical development, of which 10 in phase I, 18 in phase II and 9 in phase III, 3 products in preclinical development, and 4 products in commercial phase. Net sales are distributed geographically as follows: the United States (55.1%), Europe (18.5%) and other (26.4%).
Employees
4,700
Date Price Change Volume
26-08-14 ARS 5,225.00 -1.04% 35,638
26-08-13 ARS 5,280.00 -0.85% 153,322
26-08-12 ARS 5,325.00 +5.13% 160,490
26-08-11 ARS 5,065.00 +1.76% 165,400
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
63.32USD
Average target price
50.84USD
Spread / Average Target
-19.71%

Quarterly revenue - Rate of surprise